168 related articles for article (PubMed ID: 8864542)
1. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder.
Pertwee RG; Fernando SR
Br J Pharmacol; 1996 Aug; 118(8):2053-8. PubMed ID: 8864542
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.
Pertwee RG; Fernando SR; Nash JE; Coutts AA
Br J Pharmacol; 1996 Aug; 118(8):2199-205. PubMed ID: 8864562
[TBL] [Abstract][Full Text] [Related]
3. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
6. (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
Pertwee RG; Ross RA; Craib SJ; Thomas A
Eur J Pharmacol; 2002 Dec; 456(1-3):99-106. PubMed ID: 12450575
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Coutts AA; Pertwee RG
Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
Kathmann M; Weber B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
[TBL] [Abstract][Full Text] [Related]
9. AM630, a competitive cannabinoid receptor antagonist.
Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
[TBL] [Abstract][Full Text] [Related]
10. Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.
Pertwee RG; Fernando SR; Griffin G; Ryan W; Razdan RK; Compton DR; Martin BR
Eur J Pharmacol; 1996 Nov; 315(2):195-201. PubMed ID: 8960884
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
12. Evidence that cannabinoid-induced inhibition of electrically evoked contractions of the myenteric plexus--longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP.
Coutts AA; Pertwee RG
Can J Physiol Pharmacol; 1998 Mar; 76(3):340-6. PubMed ID: 9673798
[TBL] [Abstract][Full Text] [Related]
13. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.
Gifford AN; Ashby CR
J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
[TBL] [Abstract][Full Text] [Related]
15. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
Pertwee RG; Stevenson LA; Griffin G
Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
Pertwee RG; Griffin G; Lainton JA; Huffman JW
Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
[TBL] [Abstract][Full Text] [Related]
17. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
Gifford AN; Samiian L; Gatley SJ; Ashby CR
Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
[TBL] [Abstract][Full Text] [Related]
18. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
Pertwee RG; Thomas A; Stevenson LA; Maor Y; Mechoulam R
Neuropharmacology; 2005 Jun; 48(8):1139-46. PubMed ID: 15910889
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus.
Dmitrieva N; Berkley KJ
J Neurosci; 2002 Aug; 22(16):7147-53. PubMed ID: 12177210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
